Latest filing published 12 Jun 2024 for Relay Therapeutics, Inc., €198k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jami Rubin: trading record in brief
Jami Rubin, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Relay Therapeutics, Inc. and EQRx, Inc. The record holds 3 filings, for trades running from 20 July 2020 to 10 June 2024.
The open-market record is one-sided, with 1 purchase worth €436k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 1 option exercise.
The record was last updated on 12 June 2024 with an option exercise (€198k) in Relay Therapeutics, Inc. The latest purchase dates back some time: it was published 2,302 days ago, on 21 July 2020. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jami Rubin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 42,242 shares@ US$5.04100.0% of flowCommon StockSEC:0000950170-24-072426:0
- 2,194,500 sharesCommon StockSEC:0000899243-21-049100:0
2 of 2 declarations
